Infected cardiac myxoma.

A 66-year-old male presenting with low-grade fever and general fatigue was diagnosed as having infected myxoma of the left atrium. Blood cultures grew Streptococcus mitis. He underwent urgent resection and histological examination revealed tumor cells in a mucopolysaccharide matrix and bacterial colonies along with active inflammation. Infected cardiac myxoma is extremely rare; however, it contains a potential risk of arterial embolization and so early diagnosis and urgent surgery should be considered.

Rapidly progressive glomerulonephritis associated with PR3-ANCA positive subacute bacterial endocarditis.

Patients with bacterial endocarditis often have renal complications. This report presents the case of an elderly man with rapidly progressive glomerulonephritis (RPGN) associated with subacute bacterial endocarditis (SBE) due to Enterococcus faecalis infection. The patient was positive for anti-proteinase 3-antineutrophil cytoplasmic antibody (PR3-ANCA) and rheumatoid factor (RF) with hypocomplementemia. Treatment for SBE with antibiotics and the surgical replacement of the affected valves resulted in an improvement of RPGN, the disappearance of PR3-ANCA and RF, and the normalization of hypocomplementemia. This rare case suggests the importance of recognizing the cause of positive PR3-ANCA, because SBE could be an occult cause of RPGN mimicking ANCA-associated vasculitis.

Gallbladder infarction complicating infective endocarditis.

Infective endocarditis with systemic embolization of the gallbladder vasculature is very rare. We describe a case of subacute infective endocarditis in an adult complicated by embolization of the right hepatic artery with subsequent gallbladder infarction. In these cases, appropriate antibiotic therapy should be given before and after cholecystectomy. Gallbladder resection should be performed before valve replacement to decrease the potential seeding of a prosthetic valve.

Vasculitis silviana aislada como presentación de una endocarditis bacteriana subaguda / Isolated Sylvian vasculitis as presentation of a subacute bacterial endocarditis

No disponible

No disponible

Native valve endocarditis due to Bartonella henselae in an immunocompetent man.

Culture-negative endocarditis accounts for 2.5-31% of all endocarditis cases and remains a diagnostic and therapeutic challenge. Bartonella spp. has only recently been recognized as an important cause of culture-negative endocarditis. We report a case of Bartonella henselae endocarditis occurring in an immunocompetent man who owned a cat and had previously been diagnosed with valvulopathy. Diagnosis was made only after prolonged diagnostic work-up with serology and with PCR and subsequent sequencing to identify the microorganism in the excised valves. The duration of treatment in patients with bartonella endocarditis is not clearly defined, and we decided to treat our patient with a prolonged course of antibiotic. Surgical treatment is usually necessary and was also successful in our patient. To our knowledge, this is the first case of bartonella endocarditis occurring in our geographic area.

Endocarditis en electrodo de marcapasos de resincronización cardiaca. Tratamiento quirúrgico con circulación extracorpórea / Electrode lead endocarditis in a cardiac

No disponible

Replacement of a regurgitant pulmonary valve with a stentless bioprosthesis.

Acquired surgical disease of the pulmonary valve is rare. We report a 72-year-old man who presented with subacute endocarditic pulmonary regurgitation. This lesion was surgically corrected with a stentless bioprosthesis. Previously, homografts and various xenografts have been used for replacement of the pulmonary valve both in the pediatric population and in adult patients with congenital heart disease. Pulmonary regurgitation is a rare lesion, but if it is encountered our case demonstrates that it can be successfully and easily treated with pulmonary valve replacement by using a stentless bioprosthesis.

Role of Bartonella henselae endocarditis in the nucleation of aortic valvular calcification.

A 6-year-old boy presented with fatigability, shortness of breath, and bulging neck veins. Echocardiography revealed large vegetations, aortic insufficiency, a dilated left ventricle, and bicuspid aortic valve. There was no history of immunocompromise, fevers, or feline exposures. Blood cultures were negative; antibodies against Bartonella henselae were positive. Gentamicin was administered intravenously. Ross procedure was performed and patient was discharged on antibiotics in 5 days. Native valve was thickened by scar and fibrinous vegetations. Warthin-Starry stain demonstrated coccobacilli. Light and ultrastructural morphology, and monoclonal staining implicated B. henselae. Bacterial membranes contain calcium apatite crystals. Antigenic material was present in bacteria and calcified nodules. This case illustrates calcified protobacteria becoming incorporated into scar tissue during endocarditis.

Vancomycin-induced thrombocytopenia: a case proven with rechallenge.

In a rare case of vancomycin-induced thrombocytopenia, a 50-year-old man with culture-negative subacute bacterial endocarditis underwent mitral valve replacement surgery and was treated with vancomycin. His platelet count dropped from 346 x 10(3)/mm3 to 13 x 10(3)/mm3 on postoperative day 4, and a differential diagnosis of heparin- versus drug-induced thrombocytopenia was considered. Antiheparin antibodies were detected in the patient's serum on day 5. He showed no signs of bleeding. His platelet count remained below 5 x 10(3)/mm3 despite two platelet transfusions on day 5. A hemorrhagic pericardial effusion with tamponade developed, requiring drainage. A trial with intravenous immunoglobulin led to fever and chills, and the infusion was not completed. Vancomycin was changed to clindamycin on day 9, and methylprednisolone therapy was started on day 11. On day 12, the patient's clinical condition improved, and his platelet count increased from 3 x 10(3)/mm3 to 32 x 10(3)/mm3 with no bleeding. On day 18, his platelet count was 424 x 10(3)/mm3, and he was scheduled for discharge with vancomycin therapy for a total of 6 weeks. He received a single dose of intravenous vancomycin 1 g at the hospital; his platelet count dropped to 160 x 10(3)/mm3 1 hour after the infusion and to 58 x 10(3)/mm3 12 hours later. Vancomycin was discontinued and clindamycin and prednisone were restarted. On day 20, the patient's platelet count increased to 105 x 10(3)/mm3 and he was discharged with warfarin, prednisone, and clindamycin therapy. We suspect that our patient's thrombocytopenia was due to vancomycin.

Subacute endocarditis due to Erysipelothrix rhusiopathiae.

Erysipelothrix rhusiopathiae is a rare cause of endocarditis. Most cases were observed in people working with animals. We report a case in a 45-year old man without any exposure to animals. He was admitted to our hospital because of dyspnoea. Blood cultures were drawn following fever on day 8 of hospitalisation. Erysipelothrix rhusiopathiae was cultured and echocardiography showed a vegetation on the mitral valve. Appropriate antibiotic therapy and surgical treatment led to a good outcome of the infection.

[Surgical treatment of infective endocarditis: the Essen experiences]. / Die chirurgische Therapie der infektiösen Endokarditis: Essener Erfahrungen.

BACKGROUND: Instead of immediate diagnosis and effective antibiotic treatment morbidity and mortality in infective endocarditis remains high. If the infection cannot be controlled or the disease progresses irreversible destruction of cardiac structures results. SURGICAL THERAPY: In this case surgical therapy should be considered immediately. The outcome of surgical repair is not depending on the implanted prosthesis, but solely on timing of the operation.

Right ventricular and septal anomalies complicated by subacute bacterial endocarditis.

We report the case of a 31-year-old woman with no history of heart disease. She came to the hospital with fever, dyspnea, palpitation, and edema of the lower extremities. She was found to have aortic, mitral, and pulmonary valve insufficiency, and the initial diagnosis was subacute bacterial endocarditis. At surgery, we replaced the aortic and mitral valves with mechanical prostheses and the pulmonary valve with a bioprosthesis. The prostheses were soaked intraoperatively with fluconazole and the heart chambers were irrigated with povidone-iodine to prevent infection by bacteria and fungi. We also found 2 previously unsuspected anomalies: 1 was a muscular bundle that divided the right ventricle into 2 chambers, and the other was a ventricular septal defect, 1.0 cm in diameter. We resected the muscular bundle and patched the septal defect. The patient had an uneventful postoperative course and was in New York Heart Association functional class I at the 15-month follow-up visit. We speculate that this patient's congenital anomalies made the heart more susceptible to damage from the endocarditis. Therefore, any patient who has infective endocarditis should also be examined closely for congenital defects.

Factors affecting the surgical management of infective endocarditis.

Congestive heart failure and septic embolism complicate the clinical course of patients with infective endocarditis (IE). This study reviews the clinical records of patients with systemic disease secondary to IE and stratifies their disease severity according to individual risk factors and medical, and surgical interventions. The hospital records of all patients presenting to our institution from 1992 through 1997 with heart valve destruction secondary to IE were reviewed. Ten patients with hemodynamically significant valve lesions were included in this study: seven with aortic valve disease and two with mitral valve disease, and one with combined aortic and mitral valve lesions. All were diagnosed by echocardiogram. All ten patients experienced systemic septic arterial emboli: four intracranial lesions, four visceral lesions, and three extremity arterial occlusive events. Two patients required peripheral arterial repair. Cultures revealed infection secondary to Staphylococcus aureus in five, Streptococcus species in three, Coxiella species in one, and an unidentified organism in one patient. Seven patients underwent valve replacement. Three patients died from their disease processes. Statistical significance was established by Wilcoxon rank analysis with a two-tailed P < 0.05. Patients with IE secondary to staphylococcal infections suffered a more acute and virulent disease process (P = 0.04), with a 40 per cent mortality rate in the first 48 hours. There was no increased incidence of embolization associated with longer duration of symptoms (P = 0.32). Surgical repair conferred improved clinical outcome as compared with no surgical intervention (P = 0.03). Improved patient outcome was associated with nonstaphylococcal infection (P = 0.02), and a successful initial antibiotic regimen (P = 0.03). Peripheral arterial repair was successful in both cases.

Replacement of aortic root with valved tubular prosthesis in a ten-year-old child with infective endocarditis--a case report.

Aortic root abscess, aneurysm of sinus Valsalva, severe aortic valve insufficiency, and a fragile aortic wall caused by infective endocarditis were found in a 10-year-old child. Aortic valve replacement was intended as a preoperative strategy, but one of modifications of Cabrol had to be used urgently because of aortic root rupture between right atrial and aortic connection just after pericardiotomy.

Autograft from quadrangular resection for floppy valve repair in endocarditis.

We present a case of reconstruction of the anterior leaflet in mitral valve prolapse and subacute bacterial endocarditis in which the resected prolapsing segment of the posterior leaflet was used as patch material. Competence of the valve was achieved with no recurrence of infection. Quadrangular resection of the posterior leaflet supplies presumably viable patch material for valve repair, which is particularly useful in bacterial endocarditis and when pliability is required.

Minimally invasive aortic valve surgery: technical considerations and results with the parasternal approach.

BACKGROUND: The history of surgery over the last 30 years has moved steadily toward minimally invasive surgery; more recent experience with the gall bladder, arthroscopy, and video-assisted thoracic surgery has confirmed this trend. METHODS: Our experience in minimally invasive valve surgery between July 1996 and October 1997 included 180 patients, 80 with aortic valve replacement and 100 with mitral valve replacement. The 80 aortic valve replacement patients consisted of 46 males and 34 females, with a mean age of 63 years (range 32 to 90 years) and mean New York Heart Association Functional Class 2.5. The etiology of disease was varied: degenerative in 41 patients, congenital in 17, rheumatic in 8, subacute bacterial endocarditis in 6, myxomatous in 4, and structural valve degeneration in 4. RESULTS: There were two (2.5%) operative deaths, both from multisystem organ failure. Only 16 (20%) of the 80 patients experienced new postoperative atrial fibrillation. The mean length of stay in the hospital was 5 days (range 3 to 24 days). Only 18 (23%) of the 78 surviving patients required posthospital rehabilitation, and there were no late deaths. Morbidity included cerebrovascular accident in 1 patient (1.2%), sternal infection in 1 (1.2%), groin infection in 1 (1.2%), and bleeding requiring reoperation in 1 (1.2%). CONCLUSIONS: Minimally invasive cardiac valve surgery is extremely effective and has become our current technique of choice in every mitral and aortic valve patient who does not have coronary artery disease because it reduces the length of hospital stay and cost, requires fewer blood transfusions, and stimulates less atrial fibrillation.

Is use of the pulmonary valve allograft justified as an aortic valve substitute?

Between January 1, 1990, and March 20, 1994, 56 patients had a homograft valve device placed in the aortic position. The mean age at operation was 53.3 years (range 5-77 years). Diagnosis included dominant aortic stenosis in 27 patients (48.2%) and aortic incompetence in 29 (51.8%). Thirteen patients (23.2%) had subacute bacterial endocarditis. Forty-three aortic homografts and 13 pulmonary homografts were placed. Concomitant procedures were performed in 12 patients (21.8%). The hospital mortality was 7.3% (four patients). On follow-up, three pulmonary valves have failed, two between 1 and 5 weeks post implantation. At reoperation a linear cusp fracture was found in all with no evidence of infection. All remaining patients have no, trivial, or mild, aortic regurgitation on echo and remain well. Pulmonary and aortic valves were compared for failure, P = 0.02 suggesting a significant difference between valve substitutes. In conclusion we advise caution in using pulmonary allografts in the aortic position.

Utilización de homoinjertos valvulares en cirugía cardiovascular / Use of hemograft valves in cardiovascular surgery

Basados en los resultados alentadores con el uso de homoinjertos valvulares y las múltiples ventajas de los mismos con respecto a las prótesis mecánicas y biológicas disponibles actualmente, desde junio de 1993 en la Fundación Favaloro hemos creado un banco de tejidos desarrollando un programa de criopreservación de homoinjertos valvulares según el protocolo del Dr. O'brian del Hospital Príncipe Carlos, Australia. Hasta agosto de 1994 hemos criopreservado 48 homoinjertos, 23 válvulas aórticas, 20 válvulas pulmonares, 2 válvulas mitrales y 3 conductos con aorta descendente, siendo la población de los donantes predominantemente de receptores de trasplantes cardíacos y cardiopulmonar (50 por ciento). Durante el mismo período hemos realizado 14 implantes, 10 homoinjertos (HI) aórticos con la técnica de Mini Root en posición aórtica, 1 homoinjerto aórtico en posición pulmonar y 3 HI pulmonares en la operación de Ross. El promedio de internación fue de 15 ñ 7,8 días, con 0 por ciento de mortalidad y buena función valvular evaluada por eco doppler en el postoperatorio. La indicación de preferencia fue la endocarditis bacteriana con absceso del anillo siendo el límite para otras indicaciones el escaso número de donantes en nuestro medio. Sin duda es necesario mayor tiempo de seguimiento